Pricing Log in Create free account

IN8bio, Inc. (INAB) vs Palatin Technologies, Inc. (PTN)

IN8bio, Inc. and Palatin Technologies, Inc. are both Biotechnology companies. IN8bio, Inc. and Palatin Technologies, Inc. are of similar size ($11.7M and $11.6M). IN8bio, Inc. has the higher net margin (0.00% vs −63.5%) and the lower return on invested capital (−2,948.6% vs 0.00%). Across the 13 metrics below, IN8bio, Inc. leads on 8 and Palatin Technologies, Inc. on 5.

Valuation

Metric INAB PTN Biotechnology median
P/E n/m n/m 8.50
P/S n/m 1.29 9.71
P/B 1.18 2.55 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 0.73 9.21
Earnings yield (145.95%) (49.33%) (33.15%)
Free cash flow yield (67.71%) (79.85%) (25.50%)

Profitability

Metric INAB PTN Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (65.74%) 0.00%
Net margin 0.00% (63.54%) 0.00%
Free cash flow margin 0.00% (103.07%) 0.00%
Return on equity (111.11%) (877.60%) (56.36%)
Return on assets (90.80%) (142.11%) (48.04%)
Return on invested capital (2,948.56%) 0.00% 0.00%

Growth

Metric INAB PTN Biotechnology median
Revenue growth (TTM) — 110.89% 6.02%
EPS growth (last fiscal year) 74.06% 90.79% 30.26%
Revenue growth, 5-year CAGR — 156.83% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INAB PTN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.21 4.61 4.72
Net debt to EBITDA 1.56 0.87 0.96

Dividend

Metric INAB PTN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric INAB PTN Biotechnology median
Market cap 11.68m 11.55m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack